OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.780
-0.070 (-3.78%)
Jun 5, 2026, 4:00 PM EDT - Market closed

OS Therapies Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, OS Therapies stock has a consensus rating of "Strong Buy" and an average price target of $9.40. The average 1-year stock price forecast is 428.09% higher than the current stock price, while the lowest is $6.00 (+237.08%) and the highest is $13 (+630.34%).

Price Target: $9.40 (+428.09%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$6.00$9.40$9.30$13
Change+237.08%+428.09%+422.47%+630.34%

Analyst Ratings

The average analyst rating for OS Therapies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy333332
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total444443

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Maintains
$6
BuyMaintains$6+237.08%May 20, 2026
Lake Street
Lake Street
Buy
Maintains
$14$13
BuyMaintains$14$13+630.34%May 19, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
32.91M
EPS This Year
-0.54
from -1.03
EPS Next Year
-0.11
from -0.54
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------
Gross Profit
-1.16M-1.21K----
Operating Income
-4.84M-4.45M-4.34M-6.81M-28.71M-26.50M
Net Income
-7.42M-6.25M-7.79M-8.88M-28.75M-26.61M
EPS
-----1.03-0.54
Free Cash Flow
-974.89K-198.71K1.31M-8.54M-5.07M13.80M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-
Avg-0.54
Low-

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-